MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer
Date
2014
Authors
Ward, A.
Shukla, K.
Balwierz, A.
Soons, Z.
König, R.
Sahin, O.
Wiemann, S.
Editor(s)
Advisor
Supervisor
Co-Advisor
Co-Supervisor
Instructor
Citation Stats
Series
Abstract
Source Title
Journal of Pathology
Publisher
John Wiley and Sons Ltd
Course
Other identifiers
Book Title
Keywords
Breast cancer, C19MC cluster, Cell cycle network, MicroRNAs, Tamoxifen resistance, Estrogen receptor alpha, MicroRNA, Microrna 519a, Phosphatidylinositol 3 kinase, Small untranslated RNA, Tamoxifen, Unclassified drug, Algorithm, Apoptosis, Article, Breast cancer, Cell cycle progression, Cell viability, Controlled study, Correlation analysis, Disease specific survival, Estrogen receptor positive breast cancer, Gain of function mutation, Gene control, Gene expression, Gene targeting, Human, Human cell, Loss of function mutation, Nucleotide sequence, Priority journal, Tumor suppressor gene, Breast cancer, C19MC cluster, Cell cycle network, MicroRNAs, Tamoxifen resistance, Antineoplastic Agents, Hormonal, Apoptosis, Breast Neoplasms, Cell Cycle, Cell Line, Tumor, Drug Resistance, Neoplasm, Estrogen Receptor alpha, Female, Gene Expression Regulation, Neoplastic, Genes, Tumor Suppressor, Humans, MicroRNAs, Pharmacogenetics, Phosphatidylinositol 3-Kinases, Signal Transduction, Tamoxifen, Tumor Markers, Biological
Degree Discipline
Degree Level
Degree Name
Citation
Permalink
Published Version (Please cite this version)
Language
English